Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e804ee885f7353e2e4b1e6f72a051f8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04 |
filingDate |
2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_205e3c8bfd57577f11077ad74f59cc7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_276e55a9ca8b4e779088d01d86620065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e3758fa86d37ac334c8387f2aab2f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de950d02b8abdcfaea27d570950fbd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c61b4cf0dfc40c6c43db519c6973fff4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6bc5e11be28747c6b4a722ed9b20dcd |
publicationDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2664619-A1 |
titleOfInvention |
Purine derivatives as tools for screening anti-Alzheimer compounds |
abstract |
The present invention relates to compound of formula (I):n nand their addition salts with pharmaceutically acceptable acids. n The present invention further relates to a method for an in vitro screening of candidate compounds that modulate the production of a β-amyloid peptide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3901154-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115003676-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021214315-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3388432-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472807-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021148793-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018189122-A1 |
priorityDate |
2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |